NCT06277960View on ClinicalTrials.gov

Septal Ablation for Obstructive HCM

NAActive, not recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 28, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

June 30, 2026

Conditions
Hypertrophic Obstructive Cardiomyopathy (HOCM)
Interventions
DEVICE

percutaneous intramyocardial septal radiofrequency ablation system

The device is introduced into the right ventricle and performs ablation treatment on the hypertrophic interventricular septum.

Trial Locations (1)

310016

Sir Run Run Shaw Hospital, Hangzhou

All Listed Sponsors
lead

SuZhou Sinus Medical Technologies Co.,Ltd

INDUSTRY

NCT06277960 - Septal Ablation for Obstructive HCM | Biotech Hunter | Biotech Hunter